Finance

Lists
Q1 2027 earnings • released • EPS miss -3.42% • Revenue beat +1.47%
See results
FORTIS:NSE
Fortis Healthcare Ltd
₹948.60
-0.69%
(-6.55) 1D
Aug 10, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for FORTIS...
Open
₹965.05
High
₹978.70
Low
₹944.30
Mkt. cap
720.55B
Avg. vol.
0.00
Volume
2.22M
Dividend
0.11%
Quarterly dividend
₹0.25
Ex-dividend date
Jul 24, 2026
P/E ratio
68.35
52-wk high
₹1,104.30
52-wk low
₹766.80
EPS
₹13.88
Shares outstanding
519.08M
No. of employees
15K
Open
₹965.05
High
₹978.70
Low
₹944.30
Mkt. cap
720.55B
Avg. vol.
0.00
Volume
2.22M
Dividend
0.11%
Quarterly dividend
₹0.25
Ex-dividend date
Jul 24, 2026
P/E ratio
68.35
52-wk high
₹1,104.30
52-wk low
₹766.80
EPS
₹13.88
Shares outstanding
519.08M
No. of employees
15K
Profile
Fortis Healthcare Limited is an Indian for-profit private hospital network headquartered in Gurgaon. The Fortis Memorial Research Institute in Gurgaon serves as the headquarters for Fortis Healthcare. In addition to its Gurgaon facility, Fortis Healthcare operates hospitals in the Delhi NCR, including locations in Faridabad, Noida, Vasant Kunj, and Shalimar Bagh, along with other facilities across India, Dubai, and Sri Lanka. The company currently manages 36 healthcare facilities. Wikipedia
About Fortis Healthcare Ltd
CEOAshutosh Raghuvanshi
Employees14.6K
Founded1996
HeadquartersGurugram, Haryana, India
SectorHealth care provider
Websitefortishealthcare.com
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹3.62 / ₹3.75
-3.42%miss
Revenue / Est. (INR)
25.45B / 25.08B
+1.47%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
23.31B
22.65B
23.65B
25.45B
Cost of goods sold
13.50B
13.37B
-3.56B
15.29B
Cost of revenue
13.50B
13.37B
-3.56B
15.29B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
4.29B
-
Operating expense
5.31B
5.42B
23.22B
6.01B
Total operating expenses
18.81B
18.80B
19.66B
21.30B
Operating income
4.50B
3.86B
3.98B
4.15B
Other non operating income
225.80M
82.90M
-709.53M
144.70M
EBT including unusual items
4.25B
2.66B
3.24B
3.63B
EBT excluding unusual items
4.02B
3.12B
3.33B
3.54B
Income tax expense
965.80M
682.80M
530.11M
903.80M
Effective tax rate
22.70%
25.70%
16.35%
24.89%
Other operating expenses
4.25B
4.22B
17.71B
4.79B
Net income
3.22B
1.94B
2.66B
2.66B
Net profit margin
13.81%
8.55%
11.24%
10.47%
Earnings per share
4.02
3.02
3.66
3.62
Interest and investment income
-
-
394.31M
-
Interest expense
-748.80M
-857.40M
-402.06M
-804.40M
Net interest expenses
-748.80M
-857.40M
-7.74M
-804.40M
Depreciation and amortization charges
1.06B
1.20B
1.22B
1.22B
EBITDA
5.54B
4.62B
4.87B
5.04B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps